InspireMD, Inc. (FRA:II2)

InspireMD Statistics

Total Valuation

InspireMD has a market cap or net worth of EUR 72.17 million. The enterprise value is 20.53 million.

Market Cap	72.17M
Enterprise Value	20.53M

Important Dates

The next estimated earnings date is Monday, March 9, 2026.

Earnings Date	Mar 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	42.37M
Shares Outstanding	n/a
Shares Change (YoY)	+47.64%
Shares Change (QoQ)	+44.04%
Owned by Insiders (%)	21.71%
Owned by Institutions (%)	30.88%
Float	22.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.88
PB Ratio	1.32
P/TBV Ratio	1.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.52
EV / Sales	3.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.71

Financial Position

The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.05.

Current Ratio	6.51
Quick Ratio	6.09
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -87.61% and return on invested capital (ROIC) is -53.26%.

Return on Equity (ROE)	-87.61%
Return on Assets (ROA)	-45.46%
Return on Invested Capital (ROIC)	-53.26%
Return on Capital Employed (ROCE)	-69.32%
Revenue Per Employee	100,455
Profits Per Employee	-596,597
Employee Count	86
Asset Turnover	0.12
Inventory Turnover	1.93

Taxes

In the past 12 months, InspireMD has paid 50,286 in taxes.

Income Tax	50,286
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.86%
50-Day Moving Average	1.82
200-Day Moving Average	2.09
Relative Strength Index (RSI)	49.88
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.35

Income Statement

In the last 12 months, InspireMD had revenue of EUR 6.63 million and -39.38 million in losses. Loss per share was -0.70.

Revenue	6.63M
Gross Profit	1.65M
Operating Income	-39.97M
Pretax Income	-39.33M
Net Income	-39.38M
EBITDA	-39.62M
EBIT	-39.97M
Loss Per Share	-0.70

Balance Sheet

The company has 54.04 million in cash and 2.87 million in debt, giving a net cash position of 51.16 million.

Cash & Cash Equivalents	54.04M
Total Debt	2.87M
Net Cash	51.16M
Net Cash Per Share	n/a
Equity (Book Value)	54.64M
Book Value Per Share	1.30
Working Capital	50.78M

Cash Flow

In the last 12 months, operating cash flow was -27.71 million and capital expenditures -1.34 million, giving a free cash flow of -29.05 million.

Operating Cash Flow	-27.71M
Capital Expenditures	-1.34M
Free Cash Flow	-29.05M
FCF Per Share	n/a

Margins

Gross Margin	24.91%
Operating Margin	-602.87%
Pretax Margin	-593.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InspireMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.64%
Shareholder Yield	-47.64%
Earnings Yield	-54.56%
FCF Yield	-40.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 27, 2021. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Apr 27, 2021
Split Type	Reverse
Split Ratio	0.0666666667

Scores

InspireMD has an Altman Z-Score of -2.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.87
Piotroski F-Score	3